Statement of Retraction: Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate (The Journal of Maternal-Fetal & Neonatal Medicine, (2018), 31, 8, (1045-1050), 10.1080/14767058.2017.1306509);Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 31, Issue 8, 2018, Pages 1045-1050

  El Sayed, Mohamed Adel ^a   Saleh, Said Abdel Aty ^a   Maher, Mohammad Ahmed ^a   Khidre, Asmaa Mohamed ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Fetal growth restriction; middle cerebral artery Doppler; sildenafil citrate; umbilical artery Doppler; uterine artery Doppler

Indexed keywords

PLACEBO; SILDENAFIL; VASODILATOR AGENT;

ADULT; APGAR SCORE; ARTERIAL PH; ARTICLE; BIRTH WEIGHT; COLOR DOPPLER FLOWMETRY; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS; FETUS OUTCOME; GESTATIONAL AGE; HEADACHE; HOT FLUSH; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; NEONATAL INTENSIVE CARE UNIT; PLACENTA CIRCULATION; PLACENTA PERFUSION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; TREATMENT OUTCOME; UMBILICAL ARTERY; DIAGNOSTIC IMAGING; DOPPLER ULTRASONOGRAPHY; DRUG EFFECT; FETUS DEVELOPMENT; FETUS ECHOGRAPHY; PREGNANCY; YOUNG ADULT;

ADULT; DOUBLE-BLIND METHOD; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; HUMANS; PLACENTAL CIRCULATION; PREGNANCY; SILDENAFIL CITRATE; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; VASODILATOR AGENTS; YOUNG ADULT;

EID: 85016098175     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2024.2360745     Document Type: Erratum

References (22)

1. Petersen SG, Wong SF, Urs P, et al. Early onset, severe fetal growth restriction with absent or reversed end-diastolic flow velocity waveform in the umbilical artery: perinatal and long-term outcomes. Aust N Z J Obstet Gynaecol 2009;49:45–51.
2. Wareing M, Myers JE, O’Hara M, Baker PN., Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metabol 2005;90:2550–5.
3. Zoma WD, Baker RS, Clark KE., Effects of combined use of sildenafil citrate (Viagra) and 17 beta-estradiol on ovine coronary and uterine hemodynamics. Am J Obstet Gynecol 2004;190:1291–7.
4. Panda S, Das A, Md Nowroz H., Sildenafil citrate in fetal growth restriction. J Reprod Infertil 2014;15:168–9.
5. Dilworth MR, Andersson I, Renshall LJ, et al. Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype. PLoS One 2013;8:e77748.
6. Dastjerdi MV, Hosseini S, Bayani L., Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci 2012;17:632–6.
7. Gómez O, Figueras F, Fernández S, et al. Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation. Ultrasound Obstet Gynecol 2008;32:128–32.
8. Acharya G, Wilsgaard T, Berntsen GK, et al. Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol 2005;192:937–44.
9. Paudel S, Lohani B, Gurung G, et al. Reference values for Doppler indices of the umbilical and fetal middle cerebral arteries in uncomplicated third trimester pregnancy. J Inst Med 2010;32:5–13.
10. Odibo AO, Riddick C, Pare E, et al. Cerebro-placental Doppler ratio and adverse perinatal outcomes in intrauterine growth restriction: evaluating the impact of using gestational age-specific. J Ultrasound Med 2005;24:1223–8.
11. International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) Practice Guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol 2013;41:233–9.
12. Goffinet F, Aboulker D, Paris-Llado J., Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomized controlled trial. BJOG 2001;108:510–18.
13. Bahlmann F, Reinhard I, Krummenauer F, et al. Blood flow velocity waveforms of the fetal middle cerebral artery in a normal population: reference values from 18 weeks to 42 weeks of gestation. J Perinat Med 2002;30:490–501.
14. Oyston C, Stanley JL, Oliver MH, et al. Maternal administration of sildenafil citrate alters fetal and placental growth and fetal-placental vascular resistance in the growth-restricted ovine fetus. Hypertension 2016;68:760–7.
15. Sher G, Fisch JD., Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 2002;78:1073–6.
16. von Dadelszen P, Dwinnell S, Magee LA, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 2011;118:624–8.
17. Trapani A, Gonçalves LF, Trapani TF, et al. Comparison between transdermal nitroglycerin and sildenafil citrate in intrauterine growth restriction: effects on uterine, umbilical and fetal middle cerebral artery pulsatility indices. Ultrasound Obstet Gynecol 2016;48:61–5.
18. Samangaya RA, Mires G, Shennan A, et al. randomized, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia. Hypertens Pregnancy 2009; 28:369–82.
19. Giuliano F, Jackson G, Montorsi F, et al. Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. Int J Clin Pract 2010;64:240–55.
20. El-Far M, Hashem IMA., Novel biopharmaceutical use of sildenafil citrate in treatment of unexplained recurrent miscarriage: first longitudinal clinical study of 50 cases from Egypt. World J Pharm Pharmaceut Sci 2014; 3:63–86.
21. Dunn L, Greer R, Flenady V, Kumar S., Sildenafil in pregnancy: a systematic review of maternal tolerance and obstetric and perinatal outcomes. Fetal Diagn Ther 2017;41:81–8.
22. Trapani A, Jr, Goncalves LF, Trapani TF, et al. Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial. Obstet Gynecol 2016;128:253–9.